MELD-Plus:一个可泛化的肝硬化预测风险评分

MELD-Plus是一个基于美国大型电子病历数据开发的肝硬化患者出院后90天死亡风险预测评分,使用9个结构化变量,性能优于传统MELD评分。

Figshare
2017-10-26 更新
浏览 20
表格MGHBWHrisk scoreMELD-Nanovel MELD-Plus risk scoreAUROCMassachusetts General Hospital1- year modelcirrhosis-related admissionblood cell countCIgeneralizable prediction risk score
The MELD-Plus: A generalizable prediction risk score in cirrhosis

基本信息

模态
表格
大小
0.000152931 GB
许可
CC BY 4.0
创建/更新时间
2017-10-26
版本
v1

资源简介

MELD-Plus:一个可泛化的肝硬化预测风险评分

【数据集背景】

本数据集源站标题为《The MELD-Plus: A generalizable prediction risk score in cirrhosis》。配套论文《The MELD-Plus: A generalizable prediction risk score in cirrhosis》发表于 PLOS ONE(2017),DOI:10.1371/journal.pone.0186301。源站首次发布:2017-10-25。

【数据内容】

源站原始描述:Background and aims Accurate assessment of the risk of mortality following a cirrhosis-related admission can enable health-care providers to identify high-risk patients and modify treatment plans to decrease the risk of mortality. Methods We developed a post-discharge mortality prediction model for patients with a cirrhosis-related admission using a population of 314,292 patients who received care either at Massachusetts General Hospital (MGH) or Brigham and Women’s Hospital (BWH) between 1992 a…

【数据结构与技术规格】

文件数 4 个,合计 152.93 KB。S1 Table.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,35.51 KB。S2 Table.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,34.57 KB。S3 Table.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,41.68 KB。数据集 DOI:10.1371/journal.pone.0186301。

【主题与分类】

源站学科分类:Medicine、Microbiology、Biotechnology、Immunology、Mathematical Sciences not elsewhere classified、Infectious Diseases。主题标签:MGH、BWH、risk score、MELD-Na、novel MELD-Plus risk score、AUROC、Massachusetts General Hospital、1- year model、cirrhosis-related admission、post-discharge mortality prediction model。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面:https://plos.figshare.com/articles/dataset/The_MELD-Plus_A_generalizable_prediction_risk_score_in_cirrhosis/5538616

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Kartoun, Uri; Corey, Kathleen E.; Simon, Tracey G.; Zheng, Hui; Aggarwal, Rahul; Ng, Kenney; et al. (2017). The MELD-Plus: A generalizable prediction risk score in cirrhosis. PLOS ONE. Dataset

【使用注意】

· 源站最后修改于 2023-06-02,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "S1 Table.docx" "https://ndownloader.figshare.com/files/9590626"
curl -L -o "S2 Table.docx" "https://ndownloader.figshare.com/files/9590644"
curl -L -o "S3 Table.docx" "https://ndownloader.figshare.com/files/9590662"
curl -L -o "S4 Table.docx" "https://ndownloader.figshare.com/files/9590680"

文件清单

  • S1 Table.docx(35.51 KB)
  • S2 Table.docx(34.57 KB)
  • S3 Table.docx(41.68 KB)
  • S4 Table.docx(41.17 KB)

文件总体积 152.93 KB(源站 API 实测)。

数据加载示例(图像类)

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Background and aims
Accurate assessment of the risk of mortality following a cirrhosis-related admission can enable health-care providers to identify high-risk patients and modify treatment plans to decrease the risk of mortality.
Methods
We developed a post-discharge mortality prediction model for patients with a cirrhosis-related admission using a population of 314,292 patients who received care either at Massachusetts General Hospital (MGH) or Brigham and Women’s Hospital (BWH) between 1992 and 2010. We extracted 68 variables from the electronic medical records (EMRs), including demographics, laboratory values, diagnosis codes, and medications. We then used a regularized logistic regression to select the most informative variables and created a risk score that comprises the selected variables. To evaluate the potential for generalizability of our score, we applied it on all cirrhosis-related admissions between 2010 and 2015 at an independent EMR data source of more than 18 million patients, pooled from different health-care systems with EMRs. We calculated the areas under the receiver operating characteristic curves (AUROCs) to assess prediction performance.
Results
We identified 4,781 cirrhosis-related admissions at MGH/BWH hospitals, of which 778 resulted in death within 90 days of discharge. Nine variables were the most effective predictors for 90-day mortality, and these included all MELD-Na’s components, as well as albumin, total cholesterol, white blood cell count, age, and length of stay. Applying our nine-variable risk score (denoted as “MELD-Plus”) resulted in an improvement over MELD and MELD-Na scores in several prediction models. On the MGH/BWH 90-day model, MELD-Plus improved the performance of MELD-Na by 11.4% (0.78 [95% CI, 0.75–0.81] versus 0.70 [95% CI, 0.66–0.73]). In the MGH/BWH approximate 1-year model, MELD-Plus improved the performance of MELD-Na by 8.3% (0.78 [95% CI, 0.76–0.79] versus 0.72 [95% CI, 0.71–0.73]). Performance improvement was similar when the novel MELD-Plus risk score was applied to an independent database; when considering 24,042 cirrhosis-related admissions, MELD-Plus improved the performance of MELD-Na by 16.9% (0.69 [

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.1371/journal.pone.0186301(source: https://plos.figshare.com/articles/dataset/The_MELD-Plus_A_generalizable_prediction_risk_score_in_cirrhosis/5538616)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案